Skip to main content

Table 3 Demographic and metabolic characteristics of preeclamptic cases and normotensive controls at 12–24 gestational weeks

From: Elevated mid-trimester 4-h postprandial triglycerides for predicting late-onset preeclampsia: a prospective screening study

Variables Preeclampsia Control p value
( N = 24) ( N = 414)
( Mean ± SEM) ( Mean ± SEM)
Age (years) 30.76 ± 3.89 31.83 ± 4.19 0.35
Gravidity 2.31 ± 1.21 2.23 ± 1.01 0.90
Parity 0.53 ± 0.21 0.54 ± 0.15 0.81
Prepregnancy BMI (kg/m2) 8.07 ± 9.71 8.49 ± 12.06 0.89
Systolic Blood Pressure (mmHg) 112.81 ± 12.24 128.12 ± 10.40 0.01
Diastolic Blood Pressure (mmHg) 67.27 ± 9.18 76.72 ± 7.14 0.01
HbA1c (%) 5.06 ± 0.36 5.24 ± 0.23 0.09
FPG (mmol/L) 5.00 (4.70 ± 5.22) 4.65 (4.37 ± 4.86) 0.001
1 h PG (mmol/L) 9.62 (8.34 ± 10.59) 7.94 (6.73 ± 9.12) 0.002
2 h PG (mmol/L) 7.06 (6.47 ± 7.95) 6.91 (6.10 ± 7.81) 0.51
Total Cholesterol (mmol/L) 5.5 (5.28 ± 6.06) 5.96 (5.48 ± 6.74) 0.245
HDL-C (mmol/L) 1.79 (1.41 ± 2.18) 1.92 (1.66 ± 2.21) 0.364
LDL-C (mmol/L) 2.42 (1.96 ± 3.24) 3.13 (2.50 ± 3.57) 0.044
FFA 0.36 (0.28 ± 0.89) 0.41 (0.28 ± 0.80) 0.95
sd-LDL 40.96 (32.80 ± 55.52) 41.13 (31.71 ± 53.65) 0.72
HOMA-β (%) 121.34 (104.61 ± 133.48) 123.06 (92.38 ± 165.20) 0.606
HOMA-IR 2.25 (1.52 ± 2.86) 1.34 (1.04 ± 1.83) 0.004
FTG 2.81 (2.28 ± 3.30) 2.35 (1.88 ± 3.04) 0.12
4 h TG 4.20 (3.63 ± 5.12) 3.38 (2.44 ± 4.33) 0.037
Neonatal weight (g) 3312.63 ± 405.22 2961.66 ± 541.78 0.05
  1. Data are expressed as the mean ± SEM. BMI body mass index, FFA fasting free fat acid, FPG fasting plasma glucose, FTG fasting triglyceride, HbA1c hemoglobin A1c, HDL-C high-density lipoprotein-cholesterol; HOMA-IR homeostasis model assessment for insulin resistance index, HOMA-β homeostasis model assessment for β cell function, LDL-C low-density lipoprotein-cholesterol, sd-LDL fasting small dense low density lipoprotein, SEM standard error of the mean, 1 h PG 1 h plasma glucose, 2 h PG 2 h plasma glucose, 4 h TG 4-h triglyceride